Phase II study of a PARP inhibitor in somatic BRCA1/2 mutant metastatic breast cancer (MBC)Neelima Vidula,Senthil Damodaran,Manali A. Bhave,Hope S. Rugo,Erica Blouch,Nathan Royce Ruffle-Deignan,Ami N. Shah,Massimo Cristofanilli,Vandana G. Abramson,Joseph A. Sparano,Harry Ostrer,Nora K. Horick,Aditya BardiaJOURNAL OF CLINICAL ONCOLOGY(2023)引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要